Sarcopenia-specific interventions

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • 1 finding against

Outcomes

1

IGF-1

no changein humans1upin humans1

1 study
  1. Sarcopenia-specific interventions have no effect on IGF-1 in humans.

    “However, this change was not significant when analyses were restricted to RCTs reporting significant improvement in key sarcopenia measures.”

    Reviewanalysis restricted to RCTs reporting significant improvement in key sarcopenia measuresblood

    Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis

    Aging cell12 Jan 2026

  2. Sarcopenia-specific interventions increase IGF-1 in humans (SMD 0.46, 95% CI 0.04–0.88).

    “Among non-muscle-specific BBMs, IGF-1 was significantly impacted by the studied interventions (SMD = 0.46, CI = [0.04; 0.88]).”

    Reviewsarcopeniablood

    Frequently Reported Blood Biomarkers in Sarcopenia Clinical Trials: A Systematic Review and Meta-Analysis

    Aging cell12 Jan 2026

More on IGF-1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months